{"title":"Oncology","description":null,"products":[{"product_id":"theranostics-and-precision-medicine-for-the-management-of-hepatocellular-carcinoma-volume-3-translational-and-clinical-outcomes","title":"Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 3: Translational and Clinical Outcomes","description":"\u003cp\u003eDescription\u003cbr\u003e\n \u003cbr\u003e\n By Ganji Purnachandra Nagaraju, Sarfraz Ahmad\u003cbr\u003e\nTheranostics and Precision Medicine for the Management of Hepatocellular Carcinoma: Translational and Clinical Outcomes, Volume Three provides comprehensive information about ongoing research and clinical data on liver cancer. The book presents detailed descriptions about diagnostics and therapeutic options for easy understanding, with a focus on precision medicine approaches to improve treatment outcomes. This updated volume discusses topics such as clinical and safety assessment of HCC patients, liver transplantation as a therapeutic option, immunotherapy interventions, and image-based surveillance. In addition, it discusses immunohistology of HCC-enabled precision medicine and artificial intelligence for hepatocellular carcinomas.\u003cbr\u003e\nThis is a valuable resource for cancer researchers, oncologists, graduate students, hepathologists and members of biomedical research who need to understand more about liver cancer to apply in their research work or clinical setting.\u003cbr\u003e\n \u003cbr\u003e\nProduct Details\u003c\/p\u003e\n\n\u003cp\u003ePublisher ‏ : ‎ Academic Press; 1st edition (May 15, 2022)\u003cbr\u003e\nLanguage ‏ : ‎ English\u003cbr\u003e\nHardcover ‏ : ‎ 468 pages\u003cbr\u003e\nISBN-10 ‏ : ‎ 0323992838\u003cbr\u003e\nISBN-13 ‏ : ‎ 978-0323992831\u003cbr\u003e\nISBN-13 ‏ : ‎ 9780323992831\u003cbr\u003e\neText ISBN: 9780323992848\u003c\/p\u003e","brand":"DR. ALBERT","offers":[{"title":"Default Title","offer_id":42977426112583,"sku":null,"price":35.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0692\/2167\/9175\/files\/content_7acde7de-af13-44f2-bfd9-8a55564e6015.jpg?v=1784405353"},{"product_id":"colon-cancer-an-issue-of-surgical-oncology-clinics-of-north-america","title":"Colon Cancer, An Issue of Surgical Oncology Clinics of North America","description":"\u003cp\u003eDescription\u003cbr\u003e\n \u003cbr\u003e\n By Mark W. Arnold MD\u003c\/p\u003e\n\n\u003cp\u003eThis issue of Surgical Oncology Clinics of North America, guest edited by Dr. Mark Arnold, is devoted to Colon Cancer. Dr. Arnold has assembled expert authors to review the following topics: Chemotherapy for Colon Cancer; Colon Cancer: What We Eat; Colon Cancer: Inflammatory Associated Cancer; Colon Cancer: The Imaging Conundrum; Minimally Invasive Surgical Approaches to Colon Cancer; Population Screening for Hereditary Colorectal Cancer; The Economics of Colon Cancer; Clinical Trials in Colon Cancer; Advanced Colonoscopic Techniques; Surgical Treatment of Metastatic Disease; The Metastatic Lymph Node; and more! \u003cbr\u003e\nProduct Details\u003c\/p\u003e\n\n\u003cp\u003ePublisher ‏ : ‎ Elsevier; 1st edition (March 15, 2018)\u003cbr\u003e\nLanguage ‏ : ‎ English\u003cbr\u003e\nISBN-10 ‏ : ‎ 032358330X\u003cbr\u003e\nISBN-13 ‏ : ‎ 978-0323583305\u003c\/p\u003e","brand":"DR. ALBERT","offers":[{"title":"Default Title","offer_id":42977428734023,"sku":null,"price":35.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0692\/2167\/9175\/files\/content_1f19eac3-4725-45cc-914f-ad6e605da55a.jpg?v=1784405427"},{"product_id":"colorectal-cancer-an-issue-of-surgical-oncology-clinics-of-north-america","title":"Colorectal Cancer, An Issue of Surgical Oncology Clinics of North America","description":"\u003cp\u003eDescription\u003cbr\u003e\n \u003cbr\u003e\n By Traci L. Hedrick\u003c\/p\u003e\n\n\u003cp\u003eIn this issue of Surgical Oncology Clinics, guest editor Dr. Traci L. Hedrick brings her considerable expertise to the topic of Colorectal Cancer. Excluding skin cancers, colorectal cancer remains the third most common cancer diagnosed in both men and women in the United States. In this issue, top experts in the field provide current discussions on surgery of rectal cancer, colon cancer, targeted therapies, technological advances, genetics of colorectal cancer, and health disparities.\u003c\/p\u003e\n\n\u003cp\u003eContains 12 relevant, practice-oriented topics including preoperative staging and evaluation of colorectal cancer; technological advances in the surgical treatment of colorectal cancer; surgical principles of rectal cancer; targeted therapy for colorectal cancer; surgical principles of colon cancer; molecular genetics of colorectal cancer\/hereditary colorectal cancer syndromes; and more.\u003cbr\u003e\nProvides in-depth clinical reviews on colorectal cancer, offering actionable insights for clinical practice.\u003cbr\u003e\nPresents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.\u003c\/p\u003e\n\n\u003cp\u003e \u003cbr\u003e\nProduct Details\u003c\/p\u003e\n\n\u003cp\u003eASIN ‏ : ‎ B09XV6VW7D\u003cbr\u003e\nPublisher ‏ : ‎ Elsevier (April 7, 2022)\u003cbr\u003e\nPublication date ‏ : ‎ April 7, 2022\u003cbr\u003e\nLanguage ‏ : ‎ English\u003cbr\u003e\nSimultaneous device usage ‏ : ‎ Up to 4 simultaneous devices, per publisher limits\u003cbr\u003e\nSticky notes ‏ : ‎ On Kindle Scribe\u003cbr\u003e\nPage numbers source ISBN ‏ : ‎ 0323849008\u003c\/p\u003e","brand":"DR. ALBERT","offers":[{"title":"Default Title","offer_id":42977428766791,"sku":null,"price":35.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0692\/2167\/9175\/files\/content_a2265984-fb01-4f12-a0ab-9a75d18bd2ea.jpg?v=1784405428"},{"product_id":"current-management-of-pancreatic-cancer-an-issue-of-surgical-oncology-clinics-of-north-america","title":"Current Management of Pancreatic Cancer, An Issue of Surgical Oncology Clinics of North America","description":"\u003cp\u003eDescription\u003cbr\u003e\n \u003cbr\u003e\n By Susan Tsai MD MPH, Douglas B. Evans\u003c\/p\u003e\n\n\u003cp\u003eCurrent Management of Pancreatic Cancer, An Issue of Surgical Oncology Clinics of North America (Volume 30-4) (The Clinics: Surgery, Volume 30-4)Elsevier - Health Sciences Division9780323813594GTIN-13\/ISBN-13\/EAN0323813593Higher EducationMedicine \u0026amp; Health SciencesMedicine`Textbook Current Management of Pancreatic Cancer, An Issue of Surgical Oncology Clinics of North America (Volume 30-4) (The Clinics: Surgery, Volume 30-4)Elsevier - Health Sciences Division9780323813594GTIN-13\/ISBN-13\/EAN0323813593Higher EducationMedicine \u0026amp; Health SciencesMedicine`Textbook \u003cbr\u003e\nProduct Details\u003c\/p\u003e\n\n\u003cp\u003ePublisher ‏ : ‎ Elsevier (November 22, 2021)\u003cbr\u003e\nLanguage ‏ : ‎ English\u003cbr\u003e\nHardcover ‏ : ‎ 240 pages\u003cbr\u003e\nISBN-10 ‏ : ‎ 0323813593\u003cbr\u003e\nISBN-13 ‏ : ‎ 978-0323813594\u003c\/p\u003e","brand":"DR. ALBERT","offers":[{"title":"Default Title","offer_id":42977428799559,"sku":null,"price":35.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0692\/2167\/9175\/files\/content_a0fb005a-3047-4b61-a456-c56953c242a1.jpg?v=1784405430"},{"product_id":"management-of-gi-and-pancreatic-neuroendocrine-tumors-an-issue-of-surgical-oncology-clinics-of-north-america","title":"Management of GI and Pancreatic Neuroendocrine Tumors,An Issue of Surgical Oncology Clinics of North America","description":"\u003cp\u003eDescription\u003cbr\u003e\n \u003cbr\u003e\n By James R. Howe MD\u003c\/p\u003e\n\n\u003cp\u003eThis issue of Surgical Oncology Clinics of North America, guest edited by Dr. James Howe, is devoted to Management of GI and Pancreatic Neuroendocrine Tumors. Dr. Howe has assembled expert authors to review the following topics: Introduction and History of GI and Pancreatic Neuroendocrine Tumors (GEPNETs); Surgical Management of Colorectal Neuroendocrine Tumors; Management of Metastatic GEPNETs; Pathologic considerations in GEPNETs; Medical Management of GEPNETs; Workup of GEPNETs; Peptide Radioreceptor Therapy (PRRT); Surgical Management of Small Bowel Neuroendocrine Tumors; The Role of Functional Imaging in GEPNETs; Surgical Management of Pancreatic Neuroendocrine Tumors; Surgical Management of Other Gastric and Duodenal Neuroendocrine Tumors; and more! \u003cbr\u003e\nProduct Details\u003c\/p\u003e\n\n\u003cp\u003ePublisher ‏ : ‎ Elsevier (April 3, 2020)\u003cbr\u003e\nLanguage ‏ : ‎ English\u003cbr\u003e\nHardcover ‏ : ‎ 240 pages\u003cbr\u003e\nISBN-10 ‏ : ‎ 0323696015\u003cbr\u003e\nISBN-13 ‏ : ‎ 978-0323696012\u003c\/p\u003e","brand":"DR. ALBERT","offers":[{"title":"Default Title","offer_id":42977428832327,"sku":null,"price":35.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0692\/2167\/9175\/files\/content_a114c773-1b6f-4390-9255-e5f16eda4168.jpg?v=1784405431"},{"product_id":"management-of-metastatic-liver-tumors-an-issue-of-surgical-oncology-clinics-of-north-america","title":"Management of Metastatic Liver Tumors, An Issue of Surgical Oncology Clinics of North America","description":"\u003cp\u003eDescription\u003cbr\u003e\n \u003cbr\u003e\n By Michael D'Angelica\u003c\/p\u003e\n\n\u003cp\u003eThis issue of Surgical Oncology Clinics of North America, guest edited by Dr. Michael I. D'Angelica, is devoted to Management of Metastatic Liver Tumors. Dr. D'Angelica has assembled expert authors to review the following topics: Surgical management of liver metastases of colorectal cancer; Surgical management of liver metastases of breast cancer; Surgical management of liver metastases of neuroendocrine tumors; Surgical management of liver metastases of sarcoma (including GIST); Surgical management of liver metastases of gynecologic cancers; Surgical management of liver metastases of genitourinary cancers; Surgical management of liver metastases of uveal and dermal melanoma; Is there a role for locoregional therapies for non-colorectal GI malignancies?; Intra-arterial chemotherapy for liver metastases; External beam radiation for liver metastases; Isolated hepatic perfusion for liver metastases; Debate: Improvements in systemic therapies for liver metastases will soon render locoregional treatments obsolete; Debate: Improvements in systemic therapies for liver metastases will increase the role of locoregional treatments; and more! \u003cbr\u003e\nProduct Details\u003c\/p\u003e\n\n\u003cp\u003ePublisher ‏ : ‎ Elsevier (December 4, 2020)\u003cbr\u003e\nLanguage ‏ : ‎ English\u003cbr\u003e\nHardcover ‏ : ‎ 240 pages\u003cbr\u003e\nISBN-10 ‏ : ‎ 0323764495\u003cbr\u003e\nISBN-13 ‏ : ‎ 978-0323764490\u003c\/p\u003e","brand":"DR. ALBERT","offers":[{"title":"Default Title","offer_id":42977428865095,"sku":null,"price":35.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0692\/2167\/9175\/files\/content_d790a013-31ef-47de-a7f0-bbe81a15a55b.jpg?v=1784405432"},{"product_id":"treatment-of-peritoneal-metastasis-an-issue-of-surgical-oncology-clinics-of-north-america","title":"Treatment of Peritoneal Metastasis, An Issue of Surgical Oncology Clinics of North America","description":"\u003cp\u003eDescription\u003cbr\u003e\n \u003cbr\u003e\n By Edward A. Levine MD\u003c\/p\u003e\n\n\u003cp\u003eThis issue of Surgical Oncology Clinics of North America, guest edited by Dr. Edward A. Levine, is devoted to Treatment of Peritoneal Metastasis.  Dr. Levine has assembled expert authors to review the following topics: History of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy; Imaging for peritoneal metastases; Patient selection for cytoreductive surgery; Pharmacodynamics and pharmacokinetics of intraperitoneal chemotherapy; Genomics and peritoneal metastases; Techniques and safety issue for intraperitoneal chemotherapy; Learning curve for cytoreductive surgery; Peritoneal metastases from gastric cancer; Peritoneal metastases from mesothelioma; Peritoneal metastases from appendiceal cancer; Peritoneal metastasis from colorectal cancer; Peritoneal metastases from ovarian cancer; Palliative care of advanced peritoneal disease; and more! \u003cbr\u003e\nProduct Details\u003c\/p\u003e\n\n\u003cp\u003ePublisher ‏ : ‎ Elsevier; 1st edition (August 10, 2018)\u003cbr\u003e\nLanguage ‏ : ‎ English\u003cbr\u003e\nISBN-10 ‏ : ‎ 032361082X\u003cbr\u003e\nISBN-13 ‏ : ‎ 978-0323610827\u003c\/p\u003e","brand":"DR. ALBERT","offers":[{"title":"Default Title","offer_id":42977428897863,"sku":null,"price":35.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0692\/2167\/9175\/files\/content_91a226cd-94bf-4bdd-bef1-ba4b049e894e.jpg?v=1784405434"},{"product_id":"pancreatic-cancer-basic-mechanisms-and-therapies","title":"Pancreatic Cancer: Basic Mechanisms and Therapies","description":"\u003cp\u003eDescription\u003cbr\u003e\n \u003cbr\u003e\n By Luni Emdad, Azeddine Atfi, Rajan Gogna, Jose G Trevino, Paul B. Fisher\u003cbr\u003e\nPancreatic Cancer: Basic Mechanisms and Therapies, Volume 159 in the Advances in Cancer Research, presents the latest release in this ongoing, well-regarded serial with invaluable information on the exciting and fast-moving field of cancer research.\u003cbr\u003e\nPancreatic cancer (PC) is the third leading cause of cancer-related deaths in the United States. Greater than 90% PCs are Pancreatic ductal adenocarcinomas (PDAC) which have a dismal estimated 5-year overall survival of only 11%. PDAC is predicted to become the second leading cause of mortality in the United States by 2030. In the clinic, the PDAC patients often present with incurable disease at the time of first diagnosis. This cancer is particularly lethal because of its propensity to spread quickly to distant organs including the lymphatic system. PDAC metastasis occurs shortly after tumor initiation and is caused by a complex interaction between autonomous tumor cells and cellular elements of the tumor microenvironment. Although PDAC remains a challenging disease to treat and a leading cause of cancer-related deaths, progress is being made in disease etiology and pathogenesis, and intensive research is focused on developing optimal treatment approaches for patients. Considering the continuous progress being made in understanding PDAC pathogenesis and designing new therapies, it was considered timely to develop an up-to-date thematic issue of Advances in Cancer Research (ACR) focused on PDAC.\u003cbr\u003e\nIn this thematic issue, we have included ten review articles by experts that cover cancer disparities, PDAC pathobiology, the roles of the tumor microenvironment, tumor heterogeneity, PC stem cells, genetic and signaling events critical for PDAC pathogenesis, Immunotherapy and chemoresistance in PDAC, and different PDAC mouse models. This special issue highlights recent research progress in PDAC, which bridges the gap between basic and clinical research.\u003c\/p\u003e\n\n\u003cp\u003eThe recent overview of Racial Disparities in Pancreatic Cancer Clinical Trials; Overview the evolution of in vivo models for PDAC\u003cbr\u003e\nUp-to-date discussion of diverse genetic and molecular signaling changes in PDAC; Role of tumor heterogeneity in therapy resistance in PDAC; Chemoresistance in PDAC and how to overcome this challenge; Current and emerging approaches and strategies for advancing targeted therapy and immunotherapy for PDAC\u003cbr\u003e\nNew insights into the role of epithelial-to-mesenchymal transition, tumor microenvironment (TME) and interactions of TME with cancer stem cells in PDAC pathogenesis, progression and therapeutic resistance\u003c\/p\u003e\n\n\u003cp\u003e \u003cbr\u003e\nProduct Details\u003c\/p\u003e\n\n\u003cp\u003ePublisher ‏ : ‎ Academic Press; 1st edition (June 15, 2023)\u003cbr\u003e\nLanguage ‏ : ‎ English\u003cbr\u003e\nHardcover ‏ : ‎ 390 pages\u003cbr\u003e\nISBN-10 ‏ : ‎ 0443133549\u003cbr\u003e\nISBN-13 ‏ : ‎ 978-0443133541\u003c\/p\u003e","brand":"DR. ALBERT","offers":[{"title":"Default Title","offer_id":42977429749831,"sku":null,"price":29.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0692\/2167\/9175\/files\/content_815e983a-72ec-493c-832d-6103ec31dd45.jpg?v=1784405468"},{"product_id":"ajcc-cancer-staging-system-anus-version-9-of-the-ajcc-cancer-staging-system","title":"AJCC Cancer Staging System: Anus: Version 9 of the AJCC Cancer Staging System","description":"\u003cp\u003eDescription\u003cbr\u003e\n \u003cbr\u003e\n By Karyn A. Goodman, Marc Gollub, Cathy Eng, James Brierley, Joel Palefsky, Donna Gress, Aleisha Williams, Richard Goldberg, Mary Kay Washington\u003c\/p\u003e\n\n\u003cp\u003eVersion 9 of the American Joint Committee on Cancer (AJCC) Cancer Staging System for the Anus. The new Version 9 Anus content is presented in a streamlined, easy-to-use format, incorporates the World Health Organization (WHO) 2020 Classification of Tumors histology codes. Physicians, registrars, researchers, and other content users will be benefit from the updated Anus content, including tables, explanatory notes and illustrations. Version 9 of the Anus Cancer Staging System becomes effective on January 1, 2023 and replaces the 8th Edition Anus cancer site content. \u003cbr\u003e\nProduct Details\u003c\/p\u003e\n\n\u003cp\u003eASIN ‏ : ‎ B0BVD5T3KG\u003cbr\u003e\nPublisher ‏ : ‎ Independently published (February 7, 2023)\u003cbr\u003e\nLanguage ‏ : ‎ English\u003cbr\u003e\nPaperback ‏ : ‎ 37 pages\u003cbr\u003e\nISBN-13 ‏ : ‎ 979-8370015540\u003c\/p\u003e","brand":"DR. ALBERT","offers":[{"title":"Default Title","offer_id":42977430700103,"sku":null,"price":25.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0692\/2167\/9175\/files\/content_406ffd10-11e3-473b-8cc1-d5bc3474f104.jpg?v=1784405490"},{"product_id":"ajcc-cancer-staging-system-appendix-version-9-of-ajcc-cancer-staging-system","title":"AJCC Cancer Staging System: Appendix: Version 9 of AJCC Cancer Staging System","description":"\u003cp\u003eDescription\u003cbr\u003e\n \u003cbr\u003e\n By Michael J. Overman, Sanjay Kakar, Norman J. Carr, Nader N. Hanna, Andreana N. Holowatyj, Donna Gress, Aleisha Williams, Richard M. Goldberg, Mary Kay Washington, Alice Chen Kitterman\u003c\/p\u003e\n\n\u003cp\u003eVersion 9 of the American Joint Committee on Cancer (AJCC) Cancer Staging System for the Appendix. The new Version 9 Appendix content is presented in a streamlined, easy-to-use format, incorporates the World Health Organization (WHO) Classification of Tumors histology codes. Physicians, registrars, researchers, and other content users will be benefit from the updated Appendix content, including tables, explanatory notes and illustrations. Version 9 of the Appendix Cancer Staging System becomes effective on January 1, 2023 and replaces the 8th Edition Appendix cancer site content. \u003cbr\u003e\nProduct Details\u003c\/p\u003e\n\n\u003cp\u003eASIN ‏ : ‎ B0BVPMHPB5\u003cbr\u003e\nPublisher ‏ : ‎ Independently published (February 7, 2023)\u003cbr\u003e\nLanguage ‏ : ‎ English\u003cbr\u003e\nPaperback ‏ : ‎ 39 pages\u003cbr\u003e\nISBN-13 ‏ : ‎ 979-8356657573\u003c\/p\u003e","brand":"DR. ALBERT","offers":[{"title":"Default Title","offer_id":42977430732871,"sku":null,"price":25.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0692\/2167\/9175\/files\/content_3bd869fe-59d4-4b04-9c85-a96db77f0820.jpg?v=1784405491"},{"product_id":"ajcc-cancer-staging-system-neuroendocrine-tumors-of-the-colon-and-rectum","title":"AJCC Cancer Staging System: Neuroendocrine Tumors of the Colon and Rectum","description":"\u003cp\u003eDescription\u003cbr\u003e\n \u003cbr\u003e\n By Chanjuan Shi, Andrew M. Bellizzi, Erik Mittra, Arvand Dasari, Donna M. Gress, Alicia J. Williams, Samantha M. Thomas, Elaine Alexander, Elliot A. Asare, Mary Kay Washington\u003c\/p\u003e\n\n\u003cp\u003eVersion 9 of the American Joint Committee on Cancer (AJCC) Cancer Staging System for Neuroendocrine Tumors of the Colon and Rectum. The new Version 9 content is presented in a streamlined, easy-to-use format, incorporates the World Health Organization (WHO) Classification of Tumors histology codes. Physicians, registrars, researchers, and other content users will be benefit from the updated content, including tables, explanatory notes and illustrations. Version 9 of the Neuroendocrine Tumors of the Colon and Rectum Cancer Staging System becomes effective on January 1, 2024 and replaces the 8th Edition Neuroendocrine Tumors of the Colon and Rectum content. \u003cbr\u003e\nProduct Details\u003c\/p\u003e\n\n\u003cp\u003eASIN ‏ : ‎ B0CJMVRDRC\u003cbr\u003e\nPublisher ‏ : ‎ American College of Surgeons; 9th edition (September 21, 2023)\u003cbr\u003e\nPublication date ‏ : ‎ September 21, 2023\u003cbr\u003e\nLanguage ‏ : ‎ English\u003c\/p\u003e","brand":"DR. ALBERT","offers":[{"title":"Default Title","offer_id":42977430765639,"sku":null,"price":25.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0692\/2167\/9175\/files\/content_0e6d7e23-32cc-4437-a258-67e1d7798ff9.jpg?v=1784405492"},{"product_id":"ajcc-cancer-staging-system-neuroendocrine-tumors-of-the-appendix","title":"AJCC Cancer Staging System: Neuroendocrine Tumors of the Appendix","description":"\u003cp\u003eDescription\u003cbr\u003e\n \u003cbr\u003e\n By Chanjuan Shi, Phillip S. Ge, Eric Mittra, Alice Wei, Donna M. Gress, Aleisha J. Williams, Martin Madera, Samantha M. Thomas, Elliot Asare, Mary Kay Washington\u003c\/p\u003e\n\n\u003cp\u003eVersion 9 of the American Joint Committee on Cancer (AJCC) Cancer Staging System for Neuroendocrine Tumors of the Appendix. The new Version 9 content is presented in a streamlined, easy-to-use format, incorporates the World Health Organization (WHO) Classification of Tumors histology codes. Physicians, registrars, researchers, and other content users will be benefit from the updated content, including tables, explanatory notes and illustrations. Version 9 of the Neuroendocrine Tumors of the Appendix Cancer Staging System becomes effective on January 1, 2024 and replaces the 8th Edition Neuroendocrine Tumors of the Appendix content. \u003cbr\u003e\nProduct Details\u003c\/p\u003e\n\n\u003cp\u003eASIN ‏ : ‎ B0CHGHQRD6\u003cbr\u003e\nPublisher ‏ : ‎ American College of Surgeons; 9th edition (September 5, 2023)\u003cbr\u003e\nPublication date ‏ : ‎ September 5, 2023\u003cbr\u003e\nLanguage ‏ : ‎ English\u003c\/p\u003e","brand":"DR. ALBERT","offers":[{"title":"Default Title","offer_id":42977430831175,"sku":null,"price":25.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0692\/2167\/9175\/files\/content_cf810bc4-5697-485a-819f-1c0faf18b3b2.jpg?v=1784405494"},{"product_id":"theranostics-and-precision-medicine-for-the-management-of-hepatocellular-carcinoma-volume-2-diagnosis-therapeutic-targets-and-molecular-mechanisms","title":"Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 2: Diagnosis, Therapeutic Targets, and Molecular Mechanisms","description":"\u003cp\u003eDescription\u003cbr\u003e\n \u003cbr\u003e\n by Ganji Purnachandra Nagaraju (Author)\u003cbr\u003e\n \u003c\/p\u003e\n\n\u003cp\u003eTheranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume Two: Diagnosis, Therapeutic Targets and Molecular Mechanisms for Hepatocellular Carcinoma Progression provides comprehensive information about ongoing research and clinical data surrounding liver cancer. The book presents detailed descriptions about diagnostics and therapeutic options for easy understanding, with a focus on precision medicine approaches to improve treatment outcomes. The volume discusses topics such as computational approaches for identification of biomarkers, enzymes and pathways of HCC, circulating and epigenetic biomarkers, drug resistance, metabolic pathways, and small molecule-target therapies. In addition, it discusses immunotherapies, immune check point inhibitors and nanotechnology-based therapies.\u003cbr\u003e\nThis book is a valuable resource for cancer researchers, oncologists, graduate students, hepathologists and members of biomedical research who need to understand more about liver cancer to apply in their research work or clinical setting.\u003cbr\u003e\nProvides detailed information on traditional and novel diagnostic tools for hepatocellular carcinoma Discusses promising targeted therapies, both available and in development, explaining the best option to use for specific cases Brings recent findings in immunotherapies, immune checkpoint inhibitors and nanotechnology-based therapeutic approaches for treatment of HCC\u003c\/p\u003e\n\n\n\u003cp\u003eProduct Details\u003c\/p\u003e\n\n\u003cp\u003ePublisher: Elsevier Science; April 2, 2022\u003cbr\u003e\nLanguage: English\u003cbr\u003e\nISBN: 9780323988070\u003cbr\u003e\nISBN: 9780323993654\u003c\/p\u003e","brand":"DR. ALBERT","offers":[{"title":"Default Title","offer_id":42977431158855,"sku":null,"price":35.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0692\/2167\/9175\/files\/content_3aaba86f-23b0-464d-83dc-29ed7fb6ca73.jpg?v=1784405503"},{"product_id":"theranostics-and-precision-medicine-for-the-management-of-hepatocellular-carcinoma-volume-1-biology-and-pathophysiology","title":"Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 1: Biology and Pathophysiology","description":"\u003cp\u003eDescription\u003cbr\u003e\n \u003cbr\u003e\n by Ganji Purnachandra Nagaraju (Author)\u003cbr\u003e\n \u003c\/p\u003e\n\n\u003cp\u003eTheranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume One: Biology and Pathophysiology provides comprehensive information about ongoing research and clinical data surrounding liver cancer. The book presents detailed descriptions about diagnostics and therapeutic options for easy understanding, with a focus on precision medicine approaches to improve treatment outcomes. This volume discusses topics such as tumor microenvironment in hepatocellular carcinoma, endoplasmic reticulum stress and unfolded protein response, effects of cirrhosis and hepatitis on the prognosis of HCC, mitochondrial metabolism, next generation sequencing, and telomerase. In addition, it discusses exosomes role in HCC progression, metastasis and chemokines.\u003cbr\u003e\nThis is a valuable resource for cancer researchers, oncologists, graduate students, hepathologists and members of biomedical research who need to understand more about liver cancer for their research work or clinical setting.\u003cbr\u003e\nProvides an updated literature review and detailed understanding of liver cancer tumor biology Discusses abnormal changes in the liver caused, resulting from, or associated with hepatocellular carcinoma from a holistic view Presents the content with fully colored images and summarizing tables for easy understanding of complex topics\u003c\/p\u003e\n\n\n\u003cp\u003eProduct Details\u003c\/p\u003e\n\n\u003cp\u003ePublisher: Elsevier Science; February 16, 2022\u003cbr\u003e\nLanguage: English\u003cbr\u003e\nISBN: 9780323988063\u003cbr\u003e\nISBN: 9780323993647\u003c\/p\u003e","brand":"DR. ALBERT","offers":[{"title":"Default Title","offer_id":42977431191623,"sku":null,"price":35.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0692\/2167\/9175\/files\/content_11628831-525d-4562-bb01-f94e6508dab6.jpg?v=1784405505"},{"product_id":"gastrointestinal-oncology-2nd-edition","title":"Gastrointestinal Oncology, 2nd edition","description":"\u003cp\u003eDescription\u003cbr\u003e\n \u003cbr\u003e\n by Janusz A. Z. Jankowski (Author)\u003c\/p\u003e\n\n\u003cp\u003eBlends quality research findings with advanced educational techniques in a uniquely comprehensive approach\u003cbr\u003e\nWritten and edited by leading international experts in the field, Gastrointestinal Oncology: A Critical Multidisciplinary Team Approach is an indispensable reference for clinicians, medical practitioners, and trainees involved in the investigation, diagnosis, and treatment of esophageal, gastric, intestinal, colonic, hepatobiliary, pancreatic, and other gastrointestinal tumors. Drawing on the most current evidence-based knowledge, this comprehensive resource reflects the current care of GI cancer patients, enabling effective clinical decision making and patient management.\u003cbr\u003e\nSetting the standard in clinical practice, Gastrointestinal Oncology remains the only truly multidisciplinary reference designed for the diverse team of clinicians responsible for different stages of cancer treatment. Specially structured clinical chapters, each representing a different role in the multidisciplinary team (MDT), allow clear presentation and quick reference of the contents. This is supported by a wealth of high-quality color photographs, line drawings, and diagrams.\u003cbr\u003e\nNow in its second edition, this authoritative reference is fully updated to reflect groundbreaking research in multiple medical fields, including the explorative use of A.I. New sections on palliative care and nutrition are accompanied by new sub-sections on molecular characterization, new targeted small molecule, receptor options, and immunological therapies for each cancer. This edition places renewed emphasis on the most ubiquitous conditions, such as colon cancer, liver cancer, and gastro-esophageal cancer.\u003cbr\u003e\nCovering the oncology of the entire gastrointestinal tract, Gastrointestinal Oncology: A Critical Multidisciplinary Team Approach is a must-have reference for the entire MDT, including gastroenterologists, hepatologists, GI surgeons, medical oncologists, radiation therapists, interventional radiologists, pathologists, nutritionists, palliative care and specialist nurses, as well as clinical scientists.\u003c\/p\u003e\n\n\u003cp\u003eProduct Details\u003c\/p\u003e\n\n\u003cp\u003ePublisher: Wiley; January 12, 2024\u003cbr\u003e\nLanguage: English\u003cbr\u003e\nISBN: 9781119756392\u003cbr\u003e\nISBN: 9781119756408\u003c\/p\u003e","brand":"DR. ALBERT","offers":[{"title":"Default Title","offer_id":42977431322695,"sku":null,"price":57.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0692\/2167\/9175\/files\/content_b1235b41-c9d5-40ed-9129-94914bf2d29e.jpg?v=1784405510"},{"product_id":"gastrointestinal-oncology-a-critical-multidisciplinary-team-approach-2nd-edition","title":"Gastrointestinal Oncology: A Critical Multidisciplinary Team Approach, 2nd Edition","description":"\u003cp\u003eDescription\u003cbr\u003e\n \u003cbr\u003e\n by Janusz A. Z. Jankowski (Author)\u003cbr\u003e\n \u003c\/p\u003e\n\n\u003cp\u003eGASTROINTESTINAL ONCOLOGY\u003cbr\u003e\nBlends quality research findings with advanced educational techniques in a uniquely comprehensive approach\u003cbr\u003e\nWritten and edited by leading international experts in the field, Gastrointestinal Oncology: A Critical Multidisciplinary Team Approach is an indispensable reference for clinicians, medical practitioners, and trainees involved in the investigation, diagnosis, and treatment of esophageal, gastric, intestinal, colonic, hepatobiliary, pancreatic, and other gastrointestinal tumors. Drawing on the most current evidence-based knowledge, this comprehensive resource reflects the current care of GI cancer patients, enabling effective clinical decision making and patient management.\u003cbr\u003e\nSetting the standard in clinical practice, Gastrointestinal Oncology remains the only truly multidisciplinary reference designed for the diverse team of clinicians responsible for different stages of cancer treatment. Specially structured clinical chapters, each representing a different role in the multidisciplinary team (MDT), allow clear presentation and quick reference of the contents. This is supported by a wealth of high-quality color photographs, line drawings, and diagrams.\u003cbr\u003e\nNow in its second edition, this authoritative reference is fully updated to reflect groundbreaking research in multiple medical fields, including the explorative use of A.I. New sections on palliative care and nutrition are accompanied by new sub-sections on molecular characterization, new targeted small molecule, receptor options, and immunological therapies for each cancer. This edition places renewed emphasis on the most ubiquitous conditions, such as colon cancer, liver cancer, and gastro-esophageal cancer.\u003cbr\u003e\nCovering the oncology of the entire gastrointestinal tract, Gastrointestinal Oncology: A Critical Multidisciplinary Team Approach is a must-have reference for the entire MDT, including gastroenterologists, hepatologists, GI surgeons, medical oncologists, radiation therapists, interventional radiologists, pathologists, nutritionists, palliative care and specialist nurses, as well as clinical scientists.\u003c\/p\u003e\n\n\n\u003cp\u003eProduct Details\u003c\/p\u003e\n\n\u003cp\u003ePublisher: Wiley; January 12, 2024\u003cbr\u003e\nLanguage: English\u003cbr\u003e\nISBN: 9781119756392\u003cbr\u003e\nISBN: 9781119756408\u003c\/p\u003e","brand":"DR. ALBERT","offers":[{"title":"Default Title","offer_id":42977431715911,"sku":null,"price":57.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0692\/2167\/9175\/files\/content_05b8743e-d09b-4db1-9329-ca1f1914bf46.jpg?v=1784405524"},{"product_id":"100-questions-answers-about-cholangiocarcinoma-gallbladder-and-bile-duct-cancers-2nd-edition","title":"100 Questions \u0026 Answers About Cholangiocarcinoma, Gallbladder, and Bile Duct Cancers, 2nd Edition","description":"\u003cp\u003eDescription\u003cbr\u003e\n \u003cbr\u003e\n By Ghassan K. Abou-Alfa, Eileen O'Reilly\u003c\/p\u003e\n\n\u003cp\u003eAdvocate For Your Care It's expected that you will have questions about biliary cancer upon diagnosis. Whether it's your own diagnosis or a diagnosis of a loved one, this easy-to-read guide provides invaluable practical knowledge such as help for preparing to meet with an oncologist, seeking a second opinion, and understanding clinical trials. 100 Questions \u0026amp; Answers About Cholangiocarcinoma, Gallbladder, and Bile Duct Cancers is a resource that empowers patients and caregivers with the information needed to navigate their treatment with realistic goals for a good quality of life and targeted long-term survivorship. The perspective of patients and doctors is provided in this book with comprehensive answers to the most asked questions with added guidance for support and access to support services. You are the best solution to your cancer care. \u003cbr\u003e\nProduct Details\u003c\/p\u003e\n\n\u003cp\u003ePublisher ‏ : ‎ Jones \u0026amp; Bartlett Learning; 2nd edition (November 29, 2021)\u003cbr\u003e\nLanguage ‏ : ‎ English\u003cbr\u003e\nPaperback ‏ : ‎ 200 pages\u003cbr\u003e\nISBN-10 ‏ : ‎ 128424847X\u003cbr\u003e\nISBN-13 ‏ : ‎ 978-1284248470\u003c\/p\u003e","brand":"DR. ALBERT","offers":[{"title":"Default Title","offer_id":42977432371271,"sku":null,"price":29.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0692\/2167\/9175\/files\/content_e960cf46-0d07-4ae9-b549-1215ff5cae04.jpg?v=1784405547"},{"product_id":"gastrointestinal-cancers-an-interdisciplinary-approach","title":"Gastrointestinal Cancers: An Interdisciplinary Approach","description":"\u003cp\u003eDescription\u003cbr\u003e\n \u003cbr\u003e\n by Nima Rezaei (Author)\u003cbr\u003e\n \u003c\/p\u003e\n\n\u003cp\u003eGastrointestinal cancers are among the most prevalent malignancies worldwide, with high rate of global cancer incidence and cancer-related death. Gastrointestinal cancers include esophageal cancer, gastric cancer, colorectal cancer, pancreatic cancer, and liver cancer, which all, except the last one, are covered in this volume.\u003cbr\u003e\nThe fourth volume of the “Interdisciplinary Cancer Research” series, entitled “Gastrointestinal Cancers: An Interdisciplinary Approach” publishes comprehensive volumes on mechanisms of gastrointestinal cancers and novel immunotherapy opportunities and presents the most updated and peer-reviewed chapters on gastrointestinal cancers therapy. This interdisciplinary series is of special value to researchers working on cell biology, immunology, biochemistry, genetics, and practitioners working on oncology and gastroenterology. This is the main concept of Cancer Immunology Project (CIP), which is a part of Universal Scientific Education and Research Network (USERN). This interdisciplinary book will be of special value for researchers, oncologists, and gastroenterologists who wish to extend their knowledge on gastrointestinal cancers.\u003c\/p\u003e\n\n\n\u003cp\u003eProduct Details\u003c\/p\u003e\n\n\u003cp\u003ePublisher: Springer Nature Switzerland; January 1, 2024\u003cbr\u003e\nLanguage: English\u003cbr\u003e\nISBN: 9783031483707\u003cbr\u003e\nISBN: 9783031483714\u003c\/p\u003e","brand":"DR. ALBERT","offers":[{"title":"Default Title","offer_id":42977434927175,"sku":null,"price":25.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0692\/2167\/9175\/files\/61SUtCdOhUL._SL1246.jpg?v=1784405585"},{"product_id":"phytonutrients-in-the-treatment-of-gastrointestinal-cancer","title":"Phytonutrients in the Treatment of Gastrointestinal Cancer","description":"\u003cp\u003eDescription\u003cbr\u003e\n \u003cbr\u003e\n By Haroon Khan\u003cbr\u003e\n Gastrointestinal cancer is one of the most prevalent causes of cancer-related deaths in the world. Recent research demonstrates that phytochemicals are critical in preventing and managing gastrointestinal cancer. The increased intake of phytochemicals could reduce the risk of cancer by inhibiting cancer cell proliferation, inducing apoptosis and autophagy, and suppressing angiogenesis as well as cancer cell metastasis. These mechanisms are also known to counter Helicobacter pylori infection and modulate gut microbiota. There is preliminary data suggesting that daily supplementation with high doses of certain vitamins combined with conventional therapeutic agents may enhance their growth inhibitory effects on tumor cells and protect normal tissues against some of their toxic effects.This book attempts to fill gaps on the role of phytonutrients in the treatment of cancer in the gastrointestinal tract (GIT). It discusses the action of individual vitamins on cellular and molecular parameters and describes how vitamins inhibit protein kinase C activity, increase the production of certain growth factors, and modulate the expression of a number of oncogenes.The book is divided into 2 parts. The first part summarizes the pathophysiology of GIT cancers and introduces readers to anticancer phytonutrients. A chapter on the status of FDA approved nutraceuticals rounds up this section. The second part of the book provides a systematic review on the different plant derived chemicals that can be used to treat GIT cancer. Each chapter in this section focuses on a specific type of phytochemical agent and its molecular mechanisms relevant to the disease.This book will give the reader a holistic view of gastrointestinal cancer treatment and the value of natural compounds in developing functional food and drugs for preventive medicine. \u003cbr\u003e\nProduct Details\u003c\/p\u003e\n\n\u003cp\u003ePublisher ‏ : ‎ Bentham Science Publishers (May 2, 2023)\u003cbr\u003e\nLanguage ‏ : ‎ English\u003cbr\u003e\nHardcover ‏ : ‎ 307 pages\u003cbr\u003e\nISBN-10 ‏ : ‎ 981504964X\u003cbr\u003e\nISBN-13 ‏ : ‎ 978-9815049640\u003c\/p\u003e","brand":"DR. ALBERT","offers":[{"title":"Default Title","offer_id":42977435484231,"sku":null,"price":27.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0692\/2167\/9175\/files\/content_b97f0c1c-3083-43c1-a26d-3e9d01eaf17a.jpg?v=1784405605"},{"product_id":"the-prognosis-of-metastatic-gastrointestinal-cancer","title":"The Prognosis of Metastatic Gastrointestinal Cancer","description":"\u003cp\u003eDescription\u003cbr\u003e\n \u003cbr\u003e\n By Giuseppe A. Colloca, Antonella Venturino \u003cbr\u003e\nSurvival of patients with metastatic cancer has increased over the past two decades as a result of a progressive improvement of regional and systemic therapies. However, oncologists' estimates of patients' predicted overall survival in metastatic cancer are imprecise. The purpose of this book is to systematize the evidence regarding the prognostic factors of metastatic gastrointestinal tumors, separating the findings with the highest level of evidence among those available for each disease by selecting studies with the highest scientific evidence level.\u003cbr\u003e\n \u003cbr\u003e\nProduct Details\u003c\/p\u003e\n\n\u003cp\u003ePublisher ‏ : ‎ CRC Press; 1st edition (October 1, 2024)\u003cbr\u003e\nLanguage ‏ : ‎ English\u003cbr\u003e\nPaperback ‏ : ‎ 252 pages\u003cbr\u003e\nISBN-10 ‏ : ‎ 103269971X\u003cbr\u003e\nISBN-13 ‏ : ‎ 978-1032699714\u003c\/p\u003e","brand":"DR. ALBERT","offers":[{"title":"Default Title","offer_id":42977435615303,"sku":null,"price":27.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0692\/2167\/9175\/files\/content_995eab71-58a5-4430-8e85-527253ca6ef8.jpg?v=1784405610"},{"product_id":"tumors-of-the-gallbladder-extrahepatic-bile-ducts-and-vaterian-system","title":"Tumors of the Gallbladder, Extrahepatic Bile Ducts, and Vaterian System","description":"\u003cp\u003eDescription\u003cbr\u003e\n \u003cbr\u003e\n By Jorge Albores-Saavedra, Donald Earl Henson, David S. Klimstra\u003cbr\u003e\nThe current edition contains new information accumulated during the last ten years on tumours and tumour-like lesions of the gallbladder, extrahepatic bile ducts and Vaterian system. Because of the increasing number of laparoscopic cholecystectomies and Whipple procedures performed, surgical pathologists now have the opportunity to examine more cancer precursors, early cancers, and adenomas of the gallbladder, extrahepatic bile ducts and ampulla of Vater than previously. These lesions are discussed in detail and profusely illustrated.Likewise, lesions that closely simulate malignant neoplasms are also described and illustrated. Also included are the giant cell neoplasms and the gastrointestinal stromal tumours as well as the new subtypes of carcinomas such as large cell neuroendocrine carcinomas and adenocarcinomas with pyloric gland or foveolar phenotype. The role of immunohistochemistry in the diagnosis of a wide variety of neoplasms is emphasised as well.This book will be a great resource to practicing pathologists and students for years to come. \u003cbr\u003e\nProduct Details\u003c\/p\u003e\n\n\u003cp\u003eASIN ‏ : ‎ 1933477342\u003cbr\u003e\nPublisher ‏ : ‎ American Registry of Pathology (30 May 2016)\u003cbr\u003e\nLanguage ‏ : ‎ English\u003cbr\u003e\nISBN-10 ‏ : ‎ 9781933477343\u003cbr\u003e\nISBN-13 ‏ : ‎ 978-1933477343\u003c\/p\u003e","brand":"DR. ALBERT","offers":[{"title":"Default Title","offer_id":42977435680839,"sku":null,"price":99.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0692\/2167\/9175\/files\/518cgkmQKRL.jpg?v=1784405612"},{"product_id":"malignancies-of-the-upper-gastrointestinal-tract-an-issue-of-hematology-oncology-clinics-of-north-america","title":"Malignancies of the Upper Gastrointestinal Tract, An Issue of Hematology\/Oncology Clinics of North America","description":"\u003cp\u003eDescription\u003cbr\u003e\n \u003cbr\u003e\n by David H. Ilson (Author)\u003c\/p\u003e\n\n\n\n\n\u003cp\u003eIn this issue of Hematology\/Oncology Clinics, guest editor David H. Ilson brings his considerable expertise to the topic of Malignancies of the Upper GI Tract.\u003c\/p\u003e\n\n\u003cp\u003eContains 12 relevant, practice-oriented topics including Advances in the Imaging of Esophageal and Gastroesophageal Junction Malignancies; Advances in Immunotherapy in Esophagogastric Cancer; Advances in Surgery and (Neo) Adjuvant Therapy in the Management of Pancreatic Cancer; Advances in the Surgical Management of Esophageal Cancer; and more.\u003cbr\u003e\nProvides in-depth clinical reviews on malignancies of the upper GI tract, offering actionable insights for clinical practice.\u003cbr\u003e\nPresents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.\u003c\/p\u003e\n\n\n\n\n\u003cp\u003eProduct Details\u003c\/p\u003e\n\n\u003cp\u003ePublisher: Elsevier; \u003cbr\u003e\nISBN: 9780443295973\u003cbr\u003e\nISBN: 9780443295966\u003cbr\u003e\nCopyright: 2024\u003c\/p\u003e","brand":"DR. ALBERT","offers":[{"title":"Default Title","offer_id":42977435942983,"sku":null,"price":35.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0692\/2167\/9175\/files\/content_c0205ee9-ae1e-4527-a37d-b3a9212a492c.jpg?v=1784405622"},{"product_id":"fast-facts-for-patients-and-supporters-cholangiocarcinoma","title":"Fast Facts for Patients and Supporters: Cholangiocarcinoma","description":"\u003cp\u003eDescription\u003cbr\u003e\n \u003cbr\u003e\n By Denlinger, Crystal, Spencer, Kristen\u003cbr\u003e\nProduct Details\u003c\/p\u003e\n\n\u003cp\u003ePublisher ‏ : ‎ S. Karger Publishing; 1st edition (April 8, 2021)\u003cbr\u003e\nLanguage ‏ : ‎ English\u003cbr\u003e\nPaperback ‏ : ‎ 48 pages\u003cbr\u003e\nISBN-10 ‏ : ‎ 3318068128\u003cbr\u003e\nISBN-13 ‏ : ‎ 978-3318068122\u003c\/p\u003e","brand":"DR. ALBERT","offers":[{"title":"Default Title","offer_id":42977436303431,"sku":null,"price":25.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0692\/2167\/9175\/files\/content_d1773aa6-0ab5-4516-9444-4bd5ff7e8bc3.jpg?v=1784405631"},{"product_id":"contemporary-management-of-esophageal-and-gastric-cancer-an-issue-of-surgical-oncology-clinics-of-north-america","title":"Contemporary Management of Esophageal and Gastric Cancer, An Issue of Surgical Oncology Clinics of North America","description":"\u003cp\u003eDescription\u003cbr\u003e\n \u003cbr\u003e\n by Smita Sihag \u0026amp; Robert E. Merritt (Author)\u003cbr\u003e\nIn this issue of Surgical Oncology Clinics, guest editors Drs. Smita Sihag and Robert E. Merritt bring their considerable expertise to the topic of Contemporary Management of Esophageal and Gastric Cancer. Top experts in the field discuss the rapidly evolving areas of systemic therapy and biomarker testing, as well as minimally invasive techniques for gastrectomy, management of major complications after esophagectomy, and much more.\u003c\/p\u003e\n\n\u003cp\u003eContains 12 relevant, practice-oriented topics including minimally invasive transhiatal esophagectomy; minimally invasive modified McKeown esophagectomy; robotic-assisted Ivor Lewis esophagectomy; minimally invasive Ivor Lewis esophagectomy; the impact of racial disparities and the social determinants of health on esophageal and gastric cancer outcomes; and more.\u003cbr\u003e\nProvides in-depth clinical reviews on contemporary management of esophageal and gastric cancer, offering actionable insights for clinical practice.\u003cbr\u003e\nPresents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.\u003c\/p\u003e\n\n\u003cp\u003eProduct Details\u003c\/p\u003e\n\n\u003cp\u003ePublisher: Elsevier; \u003cbr\u003e\nISBN: 9780443131622\u003cbr\u003e\nISBN: 9780443131615\u003cbr\u003e\nCopyright: 2024\u003c\/p\u003e","brand":"DR. ALBERT","offers":[{"title":"Default Title","offer_id":42977436434503,"sku":null,"price":35.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0692\/2167\/9175\/files\/content_11539fdd-4289-4b0f-b5c4-a9b0f93c3974.jpg?v=1784405636"},{"product_id":"exploring-the-gut-microbiome-in-cancer-from-biomarkers-to-personalized-therapies","title":"Exploring the Gut Microbiome in Cancer: From Biomarkers to Personalized Therapies","description":"\u003cp\u003eDescription\u003cbr\u003e\n \u003cbr\u003e\n By Zodwa Dlamini \u003cbr\u003e\nThis book explores the relationship between the gut microbiome and cancer, illuminating various facets from fundamental roles to personalized therapies. It provides a comprehensive overview of the impact of the gut microbiome on cancer development, offering potential for innovative diagnostic and treatment approaches.\u003c\/p\u003e \n\n\u003cp\u003eThe book discusses the role of dysbiosis in cancer development, the influence of the microbiome on treatment responses, and strategies to modulate the microbiome for enhanced therapies. \u003cbr\u003e\nIt reviews the influence of the gut microbiome on immunotherapy resistance and chemoresistance in cancer patients. \u003cbr\u003e\nAdditionally, the book presents gut microbiome biomarkers for cancer diagnosis and prognosis, the implication of the gut-brain axis on cancer development and progression, and the impact of diet and lifestyle on the microbiome.\u003c\/p\u003e \n\n\u003cp\u003eTowards the end, the book investigates the role of the gut microbiome in pediatric cancer and provides an outlook on the future challenges, technological advancements, and ethical considerations of gut microbiome research in the context of personalized cancer therapies. This book is intended for cancer researchers, medical oncologists, clinicians, pharmacologists, translational investigators, and medical students.\u003cbr\u003e\n \u003cbr\u003e\nProduct Details\u003c\/p\u003e\n\n\u003cp\u003ePublisher ‏ : ‎ CRC Press; 1st edition (October 4, 2024)\u003cbr\u003e\nLanguage ‏ : ‎ English\u003cbr\u003e\nHardcover ‏ : ‎ 250 pages\u003cbr\u003e\nISBN-10 ‏ : ‎ 1032706422\u003cbr\u003e\nISBN-13 ‏ : ‎ 978-1032706429\u003c\/p\u003e","brand":"DR. ALBERT","offers":[{"title":"Default Title","offer_id":42977436827719,"sku":null,"price":25.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0692\/2167\/9175\/files\/content_615a806f-e754-41c9-9552-52f850524488.png?v=1784405652"},{"product_id":"clinical-management-of-gastrointestinal-stromal-tumor","title":"Clinical Management of Gastrointestinal Stromal Tumor","description":"\u003cp\u003eDescription\u003cbr\u003e\n \u003cbr\u003e\n By Kaixiong Tao, Hui Cao\u003cbr\u003e\n The case-based book provides an up-to-date overview of clinical management of gastrointestinal stromal tumors (GISTs). Firstly, surgical management of GISTs by laparoscope, endoscope, robot, and laparoscope combined endoscope is introduced. Following chapters discuss preoperative treatment of GISTs and management of uncommon types of GISTs in different sites. Then targeted therapy for GISTs and authors’ exploration in therapy for advanced GISTs is presented. Last but not least, management of GISTS misdiagnosed is elucidated. With typical cases and detailed analysis, this book is a useful reference for gastrointestinal and general surgeons, as well as practitioners who are interested in this challenging malignancy. \u003cbr\u003e\nProduct Details\u003c\/p\u003e\n\n\u003cp\u003ePublisher ‏ : ‎ Springer; 2024th edition (December 21, 2024)\u003cbr\u003e\nLanguage ‏ : ‎ English\u003cbr\u003e\nHardcover ‏ : ‎ 241 pages\u003cbr\u003e\nISBN-10 ‏ : ‎ 9819993911\u003cbr\u003e\nISBN-13 ‏ : ‎ 978-9819993918\u003c\/p\u003e","brand":"DR. ALBERT","offers":[{"title":"Default Title","offer_id":42977437745223,"sku":null,"price":27.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0692\/2167\/9175\/files\/content_ce92b139-a85d-4d3e-8c64-5de5c03c2821.jpg?v=1784405684"},{"product_id":"management-of-gastric-cancer-an-issue-of-surgical-oncology-clinics","title":"Management of Gastric Cancer, An Issue of Surgical Oncology Clinics","description":"\u003cp\u003eDescription\u003cbr\u003e\n \u003cbr\u003e\n This issue of Surgical Oncology Clinics of North America, Guest Edited by Neal Wilkinson, MD, is devoted to the Management of Gastric Cancer.  Articles in this issue will focus on Epidemiology; Genetics and Prophylactic Surgery; Endoscopic Diagnosis \u0026amp; Staging; Gastric Stromal Tumors (GIST); Management of Early Stage Gastric Cancer; Endoscopic Mucosal Resection (EMR); Tailored Lymphadenectomy; Laparoscopic Resection Gastric Cancer - Western Experience; Gastric Cancer - Eastern Experience; Update of Gastric Cancer Clinical Trials; Preoperative and Postoperative Chemotherapy for Gastric Cancer; and Phase I and II Clinical Trials.\u003cbr\u003e\nEditorial Reviews\u003cbr\u003e\n \u003cbr\u003e\nAbout the Author\u003cbr\u003e\nRoswell Park Cancer Institute\u003cbr\u003e\n \u003cbr\u003e\nProduct Details\u003c\/p\u003e\n\n\u003cp\u003eSeries: The Clinics: Surgery (Book 21)\u003cbr\u003e\nHardcover: 185 pages\u003cbr\u003e\nPublisher: Saunders; 1 edition (December 29, 2011)\u003cbr\u003e\nLanguage: English\u003cbr\u003e\nISBN-10: 1455739405\u003cbr\u003e\nISBN-13: 978-1455739400\u003cbr\u003e\nISBN-13: 9781455739400\u003cbr\u003e\neText ISBN: 9781455743179\u003c\/p\u003e","brand":"DR. ALBERT","offers":[{"title":"Default Title","offer_id":42977439481927,"sku":null,"price":27.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0692\/2167\/9175\/files\/content_4c513e22-d454-4aeb-a264-194a50f668be.jpg?v=1784405742"},{"product_id":"treatment-of-peritoneal-surface-malignancies-an-issue-of-surgical-oncology-clinics-1e","title":"Treatment of Peritoneal Surface Malignancies, An Issue of Surgical Oncology Clinics, 1e","description":"\u003cp\u003eDescription\u003cbr\u003e\n \u003cbr\u003e\n This issue of the Surgical Oncology Clinics of North America, Guest Edited by Dr. Jesus Esquivel, will focus on the current status and future directions of the treatment of the most common peritoneal surface malignancies: appendix cancer, colorectal cancer, ovarian cancer, gastric cancer, and peritoneal mesothelioma. This issue will also outline some of the most common issues that arise regarding cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC), such as pharmacokinetic rationale of heat and intraperitoneal chemotherapy, HIPEC techniques and safety considerations, how to start a peritoneal surface malignancy program, anesthesia considerations during cytoreductive surgery and HIPEC, patient selection for cytoreductive surgery and HIPEC, and the role of dystemic chemotherapy in the management of peritoneal surface malignancies of appendiceal and colorectal origin.\u003cbr\u003e\n \u003cbr\u003e\nProduct Details\u003c\/p\u003e\n\n\u003cp\u003eSeries: The Clinics: Surgery\u003cbr\u003e\nHardcover\u003cbr\u003e\nPublisher: Saunders; 1 edition (October 19, 2012)\u003cbr\u003e\nLanguage: English\u003cbr\u003e\nISBN-10: 1455754242\u003cbr\u003e\nISBN-13: 978-1455754243\u003cbr\u003e\nISBN-13: 9781455754243\u003cbr\u003e\neText ISBN: 9781455754250\u003c\/p\u003e","brand":"DR. ALBERT","offers":[{"title":"Default Title","offer_id":42977439547463,"sku":null,"price":25.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0692\/2167\/9175\/files\/content_d4f95faf-dd66-4689-9b93-50d633ed2cf2.jpg?v=1784405744"},{"product_id":"gastric-cancer-an-issue-of-gastroenterology-clinics-1e","title":"Gastric Cancer, An Issue of Gastroenterology Clinics, 1e","description":"\u003cp\u003eDescription\u003cbr\u003e\n \u003cbr\u003e\n Steven Moss MD (Author)\u003cbr\u003e\n \u003cbr\u003e\nGastric cancer is the second most common cause of cancer mortality worldwide. Although the incidence of gastric cancer has declined over the past century in the United States, it remains one of the most common gastrointestinal neoplasms, particularly in immigrants and the socio-economically deprived. Recent years have seen major advances in our understanding of the pathogenesis of gastric cancer (especially regarding the importance of Helicobacter pylori and its associated inflammatory response) and the emergence of adjuvant oncologic therapies of proven benefit for advanced cases, in addition to surgery. As for gastric adenocarcinoma, elucidation of the underlying biology and molecular pathogenesis has led to much progress in the management of two other malignant gastric neoplasms, gastrointestinal stromal tumors and marginal zone B-cell (\"MALT”) lymphomas. This monograph highlights these developments, presenting an updated overview of gastric cancer that will be of interest to all practicing gastroenterologists.\u003c\/p\u003e\n\n\u003cp\u003eProduct Details\u003c\/p\u003e\n\n\u003cp\u003eSeries: The Clinics: Internal Medicine\u003cbr\u003e\nHardcover\u003cbr\u003e\nPublisher: Elsevier; 1 edition (May 17, 2013)\u003cbr\u003e\nLanguage: English\u003cbr\u003e\nISBN-10: 1455770914\u003cbr\u003e\nISBN-13: 978-1455770915\u003cbr\u003e\nISBN-13: 9781455770915\u003cbr\u003e\neText ISBN: 9781455771769\u003c\/p\u003e","brand":"DR. ALBERT","offers":[{"title":"Default Title","offer_id":42977440432199,"sku":null,"price":27.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0692\/2167\/9175\/files\/content_e03a69e2-4f74-497c-8645-fc18389f6ba4.jpg?v=1784405775"},{"product_id":"molecular-diagnostics-and-treatment-of-pancreatic-cancer","title":"Molecular Diagnostics and Treatment of Pancreatic Cancer","description":"\u003cp\u003eDescription\u003cbr\u003e\n \u003cbr\u003e\n by Asfar Azmi \u003cbr\u003e\nMolecular Diagnostics andTreatment of Pancreatic Cancer describes the different emerging applications of systems biology and howit is shaping modern pancreatic cancer research. This book begins by introducing the current state of the art knowledge, trends in diagnostics, progress in disease model systems as well as new treatment and palliative care strategies in pancreatic cancer. Specific sections are dedicated to enlighten the readers to newer discoveries that have emerged from gene expression profiling, proteomics, metabolomics and systems level analyses of pancreatic cancer datasets. First of a kind and novel network strategies to understand oncogenic Kras signaling in pancreatic tumors are presented. The attempts to computationally model and prioritize microRNAs that cause pancreatic cancer resistance are alsohighlighted.\u003cbr\u003e\nAddressing this important area, Molecular Diagnostics and Treatment of Pancreatic Cancer provides insights into important network evaluation methodologies related to pancreatic cancer related microRNAs targetome. There are dedicated chapters on critical aspects of the evolving yet controversial field of pancreatic cancer stems cells. The work concludes by discussing the applications of network sciences in pancreatic cancer drug discovery and clinical trial design.\u003c\/p\u003e\n\n\u003cp\u003eEncompasses discussion of innovative tools including expression signatures in cell lines, 3D models, animal xenograft models, primary models and patient derived samples, aiding subversion of traditional biology paradigms, and enhancing comprehension across conventional length and temporal scales\u003cbr\u003e\nCoverage includes novel applications in targeted drugs, polypharmacology, network pharmacology and other related drug development arenas - helping researchers in pancreatic cancer drug discovery\u003cbr\u003e\nSummarizes many relevant computational and clinical references from fast-evolving literature\u003cbr\u003e\nComprehensive glossary helps newer readers understand technical terms and specialized nomenclature\u003c\/p\u003e\n\n\u003cp\u003eProduct Details\u003c\/p\u003e\n\n\n\u003cp\u003eISBN-13: 9780124081031\u003cbr\u003e\nPublisher: Elsevier Science\u003cbr\u003e\nPublication date: 5\/23\/2014\u003cbr\u003e\nPages: 458\u003c\/p\u003e","brand":"DR. ALBERT","offers":[{"title":"Default Title","offer_id":42977440727111,"sku":null,"price":25.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0692\/2167\/9175\/files\/content_6687e139-ab86-4cea-b92b-8dcbeb0205d1.jpg?v=1784405787"},{"product_id":"esophageal-cancer-symptoms-management-and-prognosis","title":"Esophageal Cancer: Symptoms, Management and Prognosis","description":"\u003cp\u003eDescription\u003cbr\u003e\n \u003cbr\u003e\n [caption id=\"attachment_32426\" align=\"alignright\" width=\"184\"] Esophageal Cancer - Symptoms, Management and Prognosis[\/caption]\u003cbr\u003e\nFernando López-valdez (Author, Editor), Roberto Martí Obiol (Editor)\u003cbr\u003e\n \u003cbr\u003e\nProduct Details\u003c\/p\u003e\n\n\n\u003cp\u003eHardcover: 144 pages\u003cbr\u003e\nPublisher: Nova Science Publishers, Inc. (July 20, 2014)\u003cbr\u003e\nLanguage: English\u003cbr\u003e\nISBN-10: 1633210820\u003cbr\u003e\nISBN-13: 978-1633210820\u003c\/p\u003e","brand":"DR. ALBERT","offers":[{"title":"Default Title","offer_id":42977441448007,"sku":null,"price":27.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0692\/2167\/9175\/files\/content_6c2ff4ae-417a-4ea6-a0ed-7a789c8779da.jpg?v=1784405815"},{"product_id":"from-inflammation-to-cancer-advances-in-diagnosis-and-therapy-for-gastrointestinal-and-hepatological-diseases","title":"From Inflammation to Cancer: Advances in Diagnosis and Therapy for Gastrointestinal and Hepatological Diseases","description":"\u003cp\u003eDescription\u003cbr\u003e\n \u003cbr\u003e\n by Chi Hin Cho (Editor), Jun Yu (Editor) \u003cbr\u003e\nInflammation and cancer are two major disorders that cause huge concerns in our society. However, what one may not know is that both diseases are closely associated and, in particular, both occur in the gastrointestinal tract and liver. This book describes the mechanics of how inflammation can progress to cancer in these organs. The authors in this book comprehensively discuss the different biomarkers for early diagnosis; and current therapeutic treatments for these diseases. All of these would allow us to better understanding the pathogenesis of both diseases. As such, this book provides comprehensive information concerning the interrelationship between inflammation concerning the interrelationship between inflammation and cancer in a cohesive manner, and the information derived would benefit not only basic scientists but also clinicians who are working in these fields.\u003cbr\u003e\nProduct Details\u003c\/p\u003e\n\n\n\u003cp\u003eISBN-13: 9789814343596\u003cbr\u003e\nPublisher: World Scientific Publishing Company, Incorporated\u003cbr\u003e\nPublication date: 5\/28\/2012\u003cbr\u003e\nPages: 380\u003c\/p\u003e","brand":"DR. ALBERT","offers":[{"title":"Default Title","offer_id":42977441546311,"sku":null,"price":25.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0692\/2167\/9175\/files\/content_c8a0d007-8820-4543-b992-9cd41deb1126.jpg?v=1784405819"},{"product_id":"grading-and-staging-in-gastroenterology","title":"Grading and Staging in Gastroenterology","description":"\u003cp\u003eDescription\u003cbr\u003e\n \u003cbr\u003e\n by Guido N. J. Tytgat \u003cbr\u003e\nStaging and grading are indispensable in reaching an adequate diagnosis, to determine disease severity, to choose an appropriate therapy, and to assure the best patient care and quality of life, but up to now no one source in gastroenterology has existed. Gastroenterologists, gastrointestinal surgeons, and fellows-in-training in gastroenterology will therefore immediately recognize the practical value of Grading and Staging in Gastroenterology - a comprehensive and systematic overview of all the current and most relevant information regarding grading and staging in gastroenterology - now selected and compiled for the first time in a single volume.\u003cbr\u003e\nOrganized into three sections - Instruments for Overall Patient and Disease Assessment ; Organ and Disease-related Staging and Grading Systems, and Quality of Life Patient Assessments - readers have the option of using as an overall reference, to refer to a specific organ or disease, or by virtue of the extensive subject index, to research according to specific instrument or other relevant topics.\u003cbr\u003e\nThe following timesaving and didactic features further enhance the usefulness, and whether you are a clinician or surgeon, responsible for training, involved in research including setting up research trials, or require deeper understanding of evidence-based studies you will find making this compendium a part of your gastroenterology library a smart investment.\u003c\/p\u003e\n\n\u003cp\u003eUniform presentation — each of the grading and staging systems is anchored in a strict text structure which includes aims, comments, and exact reference\u003cbr\u003e\nPrecise and unobtrusive explanatory notes (comments) — especially useful for nurse practitioners\u003cbr\u003e\nNumerous supplementary, high-quality line drawings, and endoscopic, radiologic and histological images — clarify and elucidate where appropriate\u003cbr\u003e\nComplete and accurate reference of all original sources respective to each instrument — saves valuable research time\u003c\/p\u003e\n\n\u003cp\u003eGrading and Staging in Gastroenterology is for all gastrointestinal professionals looking for an ideal guide into the myriad of staging and grading systems in gastroenterology.\u003cbr\u003e\nProduct Details\u003c\/p\u003e\n\n\n\u003cp\u003eISBN-13: 9783131426918\u003cbr\u003e\nPublisher: Thieme\u003cbr\u003e\nPublication date: 11\/11\/2008\u003cbr\u003e\nPages: 392\u003c\/p\u003e","brand":"DR. ALBERT","offers":[{"title":"Default Title","offer_id":42977442136135,"sku":null,"price":27.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0692\/2167\/9175\/files\/content_482c338d-a638-49c2-b541-ffdc493bc568.jpg?v=1784405837"},{"product_id":"advances-in-surgical-pathology-gastric-cancer","title":"Advances in Surgical Pathology: Gastric Cancer","description":"\u003cp\u003eDescription\u003cbr\u003e\n \u003cbr\u003e\n by Dongfeng Tan (Editor), Gregory Lauwers (Editor) \u003cbr\u003e\nAdvances in Surgical Pathology: Gastric Cancer provides a concise, updated review of the pathological characteristics of gastric cancer, with an emphasis on exploring practical issues and recent developments. The book features current and emerging concepts in the field of gastric cancer, a disease whose management requires a multidisciplinary approach in which pathology plays a key role. Its six sections cover the essential histopathology of gastric cancer as well as related topics such as imaging evaluation, molecular diagnosis, and personalized treatment, among other areas of interest. Individual chapters written by international experts in the fields of pathology, gastrointestinal medical oncology, cancer epidemiology, and gastrointestinal radiology, address the fundamental issues surrounding gastric cancer, including its epidemiology, basic diagnostic features, differential diagnoses, pitfalls and complications, and treatments. Endoscopic evaluation and histology correlation are emphasized. The screening, clinical management, and treatment of gastric cancer are summarized in related book sections. Recent findings regarding the roles of immunohistochemistry and molecular testing in the diagnosis, prognosis, and personalized treatment of gastric cancer are also reviewed. The book also includes current knowledge regarding the molecular alteration of gastric cancer carcinogenesis and its impact on patient care.\u003cbr\u003e\nProduct Details\u003c\/p\u003e\n\n\n\u003cp\u003eISBN-13: 9781608316175\u003cbr\u003e\nPublisher: Lippincott Williams \u0026amp; Wilkins\u003cbr\u003e\nPublication date: 2\/1\/2011\u003cbr\u003e\nSeries: Advances in Surgical Pathology Series \u003cbr\u003e\nPages: 348\u003c\/p\u003e","brand":"DR. ALBERT","offers":[{"title":"Default Title","offer_id":42977442758727,"sku":null,"price":27.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0692\/2167\/9175\/files\/content_fa91f962-83d7-4417-81d7-455b637834f0.jpg?v=1784405857"},{"product_id":"principles-and-practice-of-gastrointestinal-oncology-2nd-edition","title":"Principles and Practice of Gastrointestinal Oncology, 2nd Edition","description":"\u003cp\u003eDescription\u003cbr\u003e\n \u003cbr\u003e\n by David P. Kelsen (Editor), John M. Daly (Editor), Scott E. Kern (Editor), Bernard Levin (Editor), Joel E. Tepper (Editor) \u003cbr\u003e\nThoroughly updated for its Second Edition, this text provides comprehensive, interdisciplinary coverage of gastrointestinal cancer, including molecular biology, diagnosis, medical, surgical, and radiation therapy, and palliative care. The initial section, Principles of Gastrointestinal Oncology, includes an expanded radiation oncology chapter, an extensively revised cancer genetics chapter, and a completely rewritten medical oncology chapter emphasizing new agents. Subsequent sections focus on esophageal, gastric, pancreatic, hepatocellular, biliary tree, and colorectal cancer. Coverage of each anatomic site includes epidemiology, screening, and prevention; molecular biology and genetics; pathology; anatomy and staging; and clinical management. The final section on uncommon cancers includes new chapters on neuroendocrine tumors and small bowel cancers.\u003cbr\u003e\nA companion Website provides instant access to the complete, fully searchable text.\u003cbr\u003e\nProduct Details\u003c\/p\u003e\n\n\n\u003cp\u003eISBN-13: 9780781776172\u003cbr\u003e\nPublisher: Lippincott Williams \u0026amp; Wilkins\u003cbr\u003e\nPublication date: 10\/1\/2007\u003cbr\u003e\nEdition description: Second Edition\u003cbr\u003e\nEdition number: 2\u003cbr\u003e\nPages: 1008\u003c\/p\u003e","brand":"DR. ALBERT","offers":[{"title":"Default Title","offer_id":42977443577927,"sku":null,"price":25.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0692\/2167\/9175\/files\/content_6f8284ea-bafa-4de2-8df5-02677bf120ee.jpg?v=1784405876"},{"product_id":"carcinoma-of-the-gallbladder-the-current-scenario-ecab","title":"Carcinoma of the Gallbladder: The Current Scenario – ECAB","description":"\u003cp\u003eDescription\u003cbr\u003e\n \u003cbr\u003e\n by Elsevier Health Sciences APAC \u003cbr\u003e\nCarcinoma of the gallbladder is the most common cancers in North India which is very difficult to treat as well as manage as it is associated with many important issues. The current volume covers the topic right from its etiopathology to its palliation and gives an overview on the current knowledge of the disease. The international authorship of this book reflects the multidisciplinary nature of the book and of the field of gallbladder cancer care. The book promises to stimulate studies to provide specific answers to some unanswered questions. Above all it will destroy the myth that gallbladder carcinoma is incurable and will thus benefit a large number of patients.\u003cbr\u003e\nThis edition focuses mainly on\u003c\/p\u003e\n\n\u003cp\u003eEtiopathogenesis of gallbladder cancer\u003cbr\u003e\nManagement of gallbladder carcinoma\u003cbr\u003e\nDiagnosis and treatment outcomes\u003cbr\u003e\nAggressive surgical management\u003cbr\u003e\nMolecular biology and pathogenesis of gallbladder cancer\u003c\/p\u003e\n\n\u003cp\u003eProduct Details\u003c\/p\u003e\n\n\n\u003cp\u003eISBN-13: 9788131239995\u003cbr\u003e\nPublisher: Elsevier Health Sciences APAC\u003cbr\u003e\nPublication date: 6\/15\/2014\u003cbr\u003e\nPages: 200\u003c\/p\u003e","brand":"DR. ALBERT","offers":[{"title":"Default Title","offer_id":42977443840071,"sku":null,"price":25.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0692\/2167\/9175\/files\/content_e109b4c5-821b-4e90-8ae0-6d083af3485e.jpg?v=1784405884"},{"product_id":"pancreatic-cancer-cystic-neoplasms-and-endocrine-tumors-diagnosis-and-management","title":"Pancreatic Cancer, Cystic Neoplasms and Endocrine Tumors: Diagnosis and Management","description":"\u003cp\u003eDescription\u003cbr\u003e\n \u003cbr\u003e\n by Hans G. Beger (Editor), Akimasa Nakao (Editor), John P. Neoptolemos (Editor), Shu You Peng (Editor), Michael G. Sarr (Editor) \u003cbr\u003e\nPancreatic Cancer, Cystic Neoplasms and Endocrine Tumors:Diagnosis and Management is a modern, expertly crafted andclinically focused guide to the diagnosis, management andbest–practice care of patients suffering from pancreatic cancer,cystic neoplasms and endocrine tumours.\u003cbr\u003e\nPacked with outstanding figures and with reference to theleading society guidelines, its main focus is on the manyendoscopic and radiologic diagnostic techniques, medical andsurgical management of both full–blown cancer and other tumors, andthe risks of each form of treatment.  Also covered in detailare issues of tumor recurrence and long–term outcome oftreatment.\u003cbr\u003e\nBrought to you by highly skilled national and internationalleaders in the specialty and an experienced editor team, this is aninvaluable guide to practicing gastroenterologists and surgeons inthe hospital and clinical environment, as well as oncologists andendocrinologists managing patients with pancreatic tumorouslesions.\u003c\/p\u003e\n\n\n\n\u003cp\u003eProduct Details\u003c\/p\u003e\n\n\n\u003cp\u003eISBN-13: 9780470673188\u003cbr\u003e\nPublisher: Wiley\u003cbr\u003e\nPublication date: 4\/27\/2015\u003cbr\u003e\nEdition number: 1\u003cbr\u003e\nPages: 456\u003c\/p\u003e","brand":"DR. ALBERT","offers":[{"title":"Default Title","offer_id":42977444692039,"sku":null,"price":25.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0692\/2167\/9175\/files\/51Wh25c9TBL.jpg?v=1784405913"},{"product_id":"adjuvant-and-neoadjuvant-therapy-in-gastrointestinal-cancer-ecab","title":"Adjuvant and Neoadjuvant Therapy in Gastrointestinal Cancer – ECAB","description":"\u003cp\u003eDescription\u003cbr\u003e\n \u003cbr\u003e\n by Elsevier Health Sciences APAC\u003c\/p\u003e \n\n\u003cp\u003eECAB Adjuvant and Neoadjuvant Therapy in Gastrointestinal Cancer\u003cbr\u003e\nProduct Details\u003c\/p\u003e\n\n\n\u003cp\u003eISBN-13: 9788131239643\u003cbr\u003e\nPublisher: Elsevier Health Sciences APAC\u003cbr\u003e\nPublication date: 12\/11\/2014\u003cbr\u003e\nSold by: Barnes \u0026amp; Noble\u003cbr\u003e\nFormat: eBook\u003cbr\u003e\nPages: 166\u003cbr\u003e\nFile size: 5 MB\u003c\/p\u003e","brand":"DR. ALBERT","offers":[{"title":"Default Title","offer_id":42977444921415,"sku":null,"price":25.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0692\/2167\/9175\/files\/content_4b5112d7-0310-41a6-9888-96c19865f13e.jpg?v=1784405920"},{"product_id":"cholangiocarcinoma","title":"Cholangiocarcinoma","description":"\u003cp\u003eDescription\u003cbr\u003e\n \u003cbr\u003e\n by Giovanni Brandi (Editor), Giorgio Ercolani (Editor)\u003cbr\u003e\nCholangiocarcinoma presents a challenge for cancer specialists all over the world. Neoplasia of the biliary tract are rare, accounting for approximately 3% of all gastrointestinal tumours with an incidence of about three per 100,000; but rates have been rising rapidly in recent years. This cancer is one of the major killers: at the time of diagnosis, less than 30% of patients are candidates for complete resection. For unresectable cholangiocarcinomas, median survival is less than one year. Given the rarity of the disease, the literature on cholangiocarcinomas is scant. However, the increasing incidence of this highly lethal malignancy should capture the attention of physicians and stimulate further research.\u003c\/p\u003e\n\n\u003cp\u003eDesigned for specialists, this book highlights the main clinicopathologic features of cholangiocarcinoma and is an essential clinical guide for oncologists, surgeons, radiotherapists, radiologists, gastroenterologists and all physicians taking care of patients with biliary tract cancers.\u003c\/p\u003e\n\n\u003cp\u003eThis book offers an expert overview of the disease starting from the embryology and anatomy of the biliary tree. Each chapter provides a detailed up-to-date description of etiopathogenetic factors, epidemiology, histopathology, molecular biology and staging, emphasizing clinical features and standard approaches to biliary tract cancer, with a summary of recent literature evidence. The book also covers the diagnostic work-up and outlines the current status of imaging techniques with an overview of recent advances in surgery and locoregional and systemic therapy, in addition to the follow-up and palliative care of cholangiocarcinoma patients.\u003cbr\u003e\nProduct Details\u003c\/p\u003e\n\n\n\u003cp\u003eHardcover: 528 pages\u003cbr\u003e\nPublisher: Nova Science Pub Inc (April 20, 2015)\u003cbr\u003e\nLanguage: English\u003cbr\u003e\nISBN-10: 1634821432\u003cbr\u003e\nISBN-13: 978-1634821438\u003c\/p\u003e","brand":"DR. ALBERT","offers":[{"title":"Default Title","offer_id":42977445216327,"sku":null,"price":25.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0692\/2167\/9175\/files\/content_8c47c7bd-b7a3-414f-850a-83ed4bc98e44.jpg?v=1784405931"},{"product_id":"colon-and-other-gastrointestinal-cancers-cancer-principles-practice-of-oncology-10th-edition","title":"Colon and Other Gastrointestinal Cancers: Cancer: Principles \u0026 Practice of Oncology, 10th edition","description":"\u003cp\u003eDescription\u003cbr\u003e\n \u003cbr\u003e\n by Vincent T DeVita Jr. MD (Editor), Theodore S. Lawrence MD PhD (Editor), Steven A. Rosenberg MD PhD (Editor)\u003c\/p\u003e\n\n\n\u003cp\u003eSelected from the world’s leading comprehensive cancer textbook, this tightly focused resource provides you with the practical, cutting-edge information you need to provide the best cancer care to each patient.  Colon and Other Gastrointestinal Cancers: Cancer: Principles \u0026amp; Practice of Oncology, 10th Edition, offers a comprehensive and balanced view of this rapidly changing field, meeting the needs of oncology practitioners, fellows, and others who need an in-depth understanding of colon and GI cancer. The print reference gives you the solid, dependable guidance you’ve come to expect from this outstanding title, and the Inkling version features new quarterly updates written by a team of experts selected by the authors.Key Features:\u003c\/p\u003e\n\n\u003cp\u003eDelivers focused, comprehensive information on colon and GI cancer drawn from the world’s leading cancer textbook, DeVita, Hellman, and Rosenberg’s Cancer:  Principles \u0026amp; Practice of Oncology.\u003cbr\u003e\nCovers the molecular biology of the esophagus, stomach, liver, pancreas and colorectal cancer; genetic testing of the stomach, colon, and pancreas; and cancers of the colon and entire GI tract.\u003cbr\u003e\nDiscusses in detail the growing importance of prevention and screening, giving you the understanding you need to improve your patients’ chances for a healthier, cancer-free life.\u003cbr\u003e\nExplains how the latest developments in biologic therapy applies to cancers of the colon and GI tract.\u003cbr\u003e\nProvides exhaustive coverage of combined modality cancer treatment, helping you determine when and how to integrate modalities in patient treatment.\u003cbr\u003e\nEnsures that you’re fully up to date thanks to easy, mobile access to quarterly updates.\u003c\/p\u003e\n\n\n\n\u003cp\u003e \u003cbr\u003e\nProduct Details\u003c\/p\u003e\n\n\u003cp\u003ePaperback: 792 pages\u003cbr\u003e\nPublisher: Wolters Kluwer; 1 Pap\/Psc edition (May 26, 2016)\u003cbr\u003e\nLanguage: English\u003cbr\u003e\nISBN-10: 1496333969\u003cbr\u003e\nISBN-13: 978-1496333964\u003cbr\u003e\n Product Dimensions: 1.2 x 8.5 x 10.8 inches\u003c\/p\u003e","brand":"DR. ALBERT","offers":[{"title":"Default Title","offer_id":42977447247943,"sku":null,"price":25.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0692\/2167\/9175\/files\/content_86cb3274-2f1f-42cf-a58b-9c0490caf201.jpg?v=1784405997"},{"product_id":"curbside-consultation-in-gi-cancer-for-the-gastroenterologist-49-clinical-questions","title":"Curbside Consultation in GI Cancer for the Gastroenterologist: 49 Clinical Questions","description":"\u003cp\u003eDescription\u003c\/p\u003e\u003cbr\u003e\n \u003cbr\u003e\n \n\n\u003cp\u003eAre you looking for concise, practical answers to questions that are often left unanswered by traditional cancer references that are not designed for gastroenterologists? Are you seeking brief, evidence-based advice for complicated cases or patients with complications that need management? Curbside Consultation in GI Cancer for the Gastroenterologist: 49 Clinical Questions provides quick and direct answers to the thorny questions commonly posed during a “curbside consultation” between colleagues.\u003cbr\u003e\nDr. Douglas G. Adler has designed this unique reference, which offers expert advice, preferences, and opinions on tough clinical questions commonly associated with GI cancer. The unique Q\u0026amp;A format provides quick access to current information related to GI cancer with the simplicity of a conversation between two colleagues. Numerous images, diagrams, and references are included to enhance the text and to illustrate the treatment of GI cancer patients.\u003cbr\u003e\nCurbside Consultation in GI Cancer for the Gastroenterologist: 49 Clinical Questions provides information basic enough for residents while also incorporating expert advice that even high-volume clinicians will appreciate. Gastroenterologists, fellows and residents in training, surgical attendings, and surgical residents will benefit from the user-friendly and casual format and the expert advice contained within.\u003cbr\u003e\nSome of the questions that are answered:\u003c\/p\u003e\n\n\u003cp\u003e• An 81-year-old man is found to have unresectable esophageal cancer and malignant dysphagia. Should he have a stent? A nasogastric feeding tube? A PEG tube?\u003c\/p\u003e\n\n\u003cp\u003e• How is tumor-related bleeding from gastric cancers best approached?\u003c\/p\u003e\n\n\u003cp\u003e• Do patients with pancreatic cancer and jaundice need to have an ERCP preoperatively?\u003c\/p\u003e\n\n\u003cp\u003e• What is the role of ERCP and EUS in patients with suspected cholangiocarcinoma?\u003c\/p\u003e\n\n\u003cp\u003e• Why are rectal cancers so different from colon cancers with regards to medical and surgical management?\u003cbr\u003e\nCurbside Consultation in GI Cancer for the Gastroenterologist: 49 Clinical Questions illustrates how patients at different points in their treatment may go back and forth between specialists to receive coordination of care, and incorporates input from gastroenterologists, surgeons, radiologists, and oncologists. While providing up-to-date information, this book will help gastroenterologists to manage complex cancer-related issues and guide physicians through the maze of cancer-related treatments available.\u003cbr\u003e\nIdeal for practicing gastroenterologists, gastroenterology fellows, surgeons, oncologists, residents, and medical students, Curbside Consultation in GI Cancer for the Gastroenterologist: 49 Clinical Questions is sure to benefit anyone caring for patients with gastrointestinal cancers.\u003c\/p\u003e\n\n\n\u003cp\u003e \u003cbr\u003e\nProduct Details\u003c\/p\u003e\n\n\u003cp\u003eSeries: Curbside Consultation in Gastroenterology\u003cbr\u003e\nPaperback: 288 pages\u003cbr\u003e\nPublisher: Slack Incorporated; 1 edition (April 15, 2011)\u003cbr\u003e\nLanguage: English\u003cbr\u003e\nISBN-10: 1556429843\u003cbr\u003e\nISBN-13: 978-1556429842\u003cbr\u003e\n Product Dimensions: 7 x 0.5 x 10 inches\u003c\/p\u003e","brand":"DR. ALBERT","offers":[{"title":"Default Title","offer_id":42977447903303,"sku":null,"price":27.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0692\/2167\/9175\/files\/content_d7cd0bf2-3f7a-4300-90cb-02e7be7a1594.jpg?v=1784406023"},{"product_id":"handbook-of-gastrointestinal-cancers-evidence-based-treatment-and-multidisciplinary-patient-care","title":"Handbook of Gastrointestinal Cancers: Evidence-Based Treatment and Multidisciplinary Patient Care","description":"\u003cp\u003eDescription\u003cbr\u003e\n \u003cbr\u003e\n Handbook of Gastrointestinal Cancers is a practical guide to the management of colorectal, pancreatic, hepatocellular, gastric, and esophageal cancers as well as other cancers of the upper and lower gastrointestinal tract. Edited by a multidisciplinary group of oncologists from leading institutions, this book is an essential day-to-day reference for evidence-based treatment and patient care. The handbook focuses on treatment strategies and approaches to cancerous gastrointestinal tumors that are transforming the recent oncological landscape, including expert-given guidance on methods such as neoadjuvant and adjuvant chemotherapy, surgical transplant, radiation therapy, molecular diagnostic testing leading to molecularly targeted therapy, and immunotherapy.\u003cbr\u003e\nWith so many advances in the current field, it is increasingly difficult for early-career practitioners to grasp the entirety of practices and for seasoned oncologists to keep up with newly approved therapies, side effects to treatments, and special clinical management considerations, but this handbook addresses it all. Organized by major gastrointestinal disease sites and featuring “How I Treat” case vignettes from world experts for common and uncommon management considerations, the handbook brings an experience-based perspective to these tough-to-treat areas. The treatment strategies and applications set forth in the chapters are pertinent to situations and decision-making encountered in practice. Handbook of Gastrointestinal Cancers is a valuable resource for medical oncologists, radiation oncologists, and surgeons treating and managing gastrointestinal cancers as well as trainees in medical, radiation, and surgical oncology programs needing an accessible point of care resource.\u003cbr\u003e\nKEY FEATURES:\u003c\/p\u003e\n\n\u003cp\u003eProvides treatment plans and recommendations for each stage of a range of gastrointestinal cancers, including colorectal, pancreatic, and hepatocellular cancers plus more\u003cbr\u003e\nIncludes “How I Treat” patient vignettes told from the physician’s point of view within each clinical chapter\u003cbr\u003e\nOutlines special considerations for the elderly and for survivors of gastrointestinal cancers\u003cbr\u003e\nHighlights important clinical guidance on nutritional and palliative concerns commonly seen in patients with gastrointestinal cancers\u003c\/p\u003e\n\n\u003cp\u003e \u003cbr\u003e\nProduct details\u003c\/p\u003e\n\n\n\u003cp\u003ePaperback: 514 pages\u003cbr\u003e\nPublisher: Demos Medical; 1 edition (August 13, 2019)\u003cbr\u003e\nLanguage: English\u003cbr\u003e\nISBN-10: 0826138128\u003cbr\u003e\nISBN-13: 978-0826138125\u003c\/p\u003e\n\n\u003cp\u003e#373 in Digestive Organ Diseases (Books)\u003cbr\u003e\n#822 in Radiology (Books)\u003cbr\u003e\n#389 in Gastroenterology (Books)\u003c\/p\u003e","brand":"DR. ALBERT","offers":[{"title":"Default Title","offer_id":42977448394823,"sku":null,"price":25.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0692\/2167\/9175\/files\/content_c9a6a856-0159-47fa-8290-9fd8d1b519a2.jpg?v=1784406043"},{"product_id":"a-practical-guide-to-peritoneal-malignancy-the-pmi-manual","title":"A Practical Guide to Peritoneal Malignancy: The PMI Manual","description":"\u003cp\u003eDescription\u003cbr\u003e\n \u003cbr\u003e\n by  Tom Cecil (Editor), John Bunni , Akash Mehta\u003cbr\u003e\nPeritoneal malignancy is a rapidly growing field within surgical oncology. National and International treatment programmes and training curricula are being established worldwide to co-ordinate treatment and management of these challenging clinical problems. A large body of evidence now exists, but the practical implications of this evidence base remain unclear. The Peritoneal Malignancy Institute in Basingstoke, the largest centre in the world, is at the forefront of new developments and techniques. This manual combines the experience of the PMI with the latest evidence to provide a practice-oriented guide to the successful set up and running of a peritoneal malignancy unit.\u003c\/p\u003e\n\n\n\n\n\u003cp\u003eProduct details\u003c\/p\u003e\n\n\n\u003cp\u003ePaperback: 191 pages\u003cbr\u003e\nPublisher: CRC Press (November 18, 2019)\u003cbr\u003e\nLanguage: English\u003cbr\u003e\nISBN-10: 1138495115\u003cbr\u003e\nISBN-13: 978-1138495111\u003cbr\u003e\nProduct Dimensions: 7.4 x 9.7 inches\u003c\/p\u003e","brand":"DR. ALBERT","offers":[{"title":"Default Title","offer_id":42977448525895,"sku":null,"price":35.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0692\/2167\/9175\/files\/content_2da15e68-e4b7-4ff5-aa05-3db2ced8cb27.jpg?v=1784406049"}],"url":"https:\/\/www.gastrolibrary.online\/collections\/oncology.oembed?page=2","provider":"Gastro","version":"1.0","type":"link"}